期刊文献+

慢性心力衰竭伴二尖瓣返流血浆NT-proBNP水平分析

Level of plasma NT-proBNP in patients with chronic heart failure and mitral regurgitation
下载PDF
导出
摘要 目的:探讨慢性心力衰竭伴二尖瓣返流(MR)患者血浆N末端脑钠肽前体(NT-proBNP)水平与MR的相关性。方法:心脏超声检测MR后将74例慢性心力衰竭患者并分为MR组(35例)和非MR组(39例),采用酶联免疫吸附法(ELISA)检测血浆NT-proBNP水平,观察两组NT-proBNP水平的差异及其与MR的相关性。结果:MR组和非MR组NT-proBNP水平分别为331.7、135.0 pg/mL,两组比较,差异有统计学意义(P<0.05);LVEF与NT-proBNP水平呈负相关(P<0.05),体质量及MR与NT-proBNP水平与呈正相关(P<0.05)。MR与NT-proBNP偏相关系数为0.672(P<0.05);心功能分级与NT-proBNP偏相关系数为0.737(P<0.05);体质量与NT-proBNP偏相关系数为0.638(P<0.05)。结论:MR是影响老年慢性心力衰竭患者NT-proBNP水平的独立因素。 Objective: To investigate the correlation between mitral regurgitation (MR) and the level of plasma N-terminal brain natriuretie peptide (NT-proBNP) in patients with chronic heart failure. Methods: Seventy-four consecutive patients with chronic heart failure were selected, and divided into two groups according to cardiac ultrasound : MR group ( n = 35 ) and non-MR group ( n = 39 ). The level of plasma NT-proBNP was detected by enzyme-linked immunosorbent assay (ELISA) for all patients on admission and the correlation between the level of NT-proBNP and MR was observed. Results: The median NT-proBNP level of the MR group was 331.7 pg/mL vs 135.0 pg/mL in the non-MR group, with a statistical difference between the both (P 〈 0. 05 ). The level of NT-proBNP was negatively correlated with LVEF ( P 〈 0.05 ) and positively correlated with body mass index and MR ( both P 〈 0.05 ). The partial correlation coefficient was 0. 672 for NT-proBNP and LVEF ( P 〈 O. 05 ) , 0. 737 for NT-proBNP and level of cardiac function ( P 〈 0.05 ) , and 0.638 for NT-proBNP and body mass index (P 〈 0.05). Conclusion : MR is an independent factor that affects the level of NT-proBNP in elderly patients with chronic heart failure.
作者 李飞 张巍
出处 《广州医学院学报》 2012年第6期51-53,共3页 Academic Journal of Guangzhou Medical College
关键词 慢性心力衰竭 二尖瓣返流 N末端脑钠肽前体 chronic heart failure mitral regurgitation NT-proBNP
  • 相关文献

参考文献9

  • 1Klaar U, Gabriel H, Bergler-Klein J, et al. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation[ J] . Eur J Heart Fail, 2011, 13(2) : 163-169.
  • 2Shaikh K, Hanif B, Siddique AA, et al. Pro-brain natriuretic Peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea [ J ] . J Coll Physicians Surg Pak, 2012, 22(12) : 751-755.
  • 3Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure [ J ] . Vasc Health Risk Manag, 2010, 6(3) :411-418.
  • 4Alehagen U, Dahlstrom U, Rehfeld JF, et al. Pro-a-type natriuretic Peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic Peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure[J] . J Card Fail, 2013, 19 (1) : 31-39.
  • 5Tamizifar B, Rismankarzadeh M. Using NT-proBNP as a criterion for heart failure hospitalization [ J ] . J Res Med Sci, 2012, 17(1): 111-113.
  • 6倪玉华.应积极手术治疗老年人二尖瓣返流[J].中华医学杂志,2006,86(37):2664-2664. 被引量:2
  • 7Prakaschandra DR, Esterhuizen T, Naidoo DP. The time- course changes of NT-proBNP and tissue Doppler indices in patients undergoing mitral valve replacement [ J ]. Cardiovasc J Afr, 2012, 23(4): 200-205.
  • 8Reynolds CA, Brown DC, Rush JE, et al. Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: the PREDICT cohort study[J] . J Vet Cardiol, 2012, 14(1): 193-202.
  • 9Magne J, Dubois M, Champagne J, et al. Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy [ J ]. Cardiovasc Ultrasound, 2009, 7 (5) : 39.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部